Lung Cancer

Lung Cancer Diagnosis Clinical Trials

Lung cancer is a serious and often deadly disease that affects millions of people worldwide. It is the leading cause of cancer-related deaths globally, highlighting the urgent need for effective early detection and screening methods. At Hightower Clinical, we are committed to advancing the fight against lung cancer through innovative research and clinical trials.

The primary objective of this clinical study is to evaluate the performance of a specific blood test in screening eligible participants for lung cancer. Enrollment will be open to all eligible participants undergoing chest CT scan screening as part of the Standard of Care (SOC) for lung cancer. Participants will provide informed consent and undergo blood sample collection within 30 days of enrollment.

Frequently Asked Questions